Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HARVARD BIOSCIENCE INCHBIO · Entity 7369 | Director | January 02, 2018 | January 04, 2018 |
| TECOGEN INC.TGEN · Entity 6846 | Director | June 26, 2026 | July 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HARVARD BIOSCIENCE INC
Report date January 02, 2018 · Filed January 04, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 477,050 |
Reported balance
After 2018-01-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-01-02 · Grant · Acquired 9,700 · Balance 477,050 F1: Represents a deferred stock award of 9,700 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018, and are subject to continued service as a non-employee director on the applicable vesting dates. These retainer awards are granted in lieu and satisfaction of the annual cash retainer compensation to be earned by the director for his service on the Issuer's Board of Directors and its Committees during 2018. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the retainers all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of November, rounded to the nearest 100 shares. F2: Includes (a) a deferred stock award of 9,700 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018; (b) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; and (c) 436,050 shares of common stock held by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a deferred stock award of 9,700 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018, and are subject to continued service as a non-employee director on the applicable vesting dates. These retainer awards are granted in lieu and satisfaction of the annual cash retainer compensation to be earned by the director for his service on the Issuer's Board of Directors and its Committees during 2018. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the retainers all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of November, rounded to the nearest 100 shares.
F2: Includes (a) a deferred stock award of 9,700 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018; (b) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; and (c) 436,050 shares of common stock held by the Reporting Person.
TECOGEN INC.
Report date June 26, 2026 · Filed July 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.17 · Expires 2036-06-26 | Direct | 25,000 |
Reported balance
After 2026-06-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-26 · Grant · Acquired 25,000 · Balance 25,000 F1: Vests 25% per year |
Filing footnotes · ownership attribution and instrument terms
F1: Vests 25% per year
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
FLIR SYSTEMS INC
Report date May 14, 2021 · Filed May 14, 2021
Section 16 reporting ended · disclosed 2021-05-14. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2021-05-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-05-14 · Disposition to issuer · Disposed 599,383 · Balance 68,308 F1: Pursuant to the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among Teledyne Technologies Incorporated ("Teledyne"), Firework Merger Sub I, Inc. ("Merger Sub I"), Firework Merger Sub II, LLC, and FLIR Systems, Inc. ("FLIR"), Merger Sub I was merged with and into FLIR on May 14, 2021, with FLIR surviving, and immediately thereafter Merger Sub II was merged with and into FLIR, with Merger Sub II surviving. In connection therewith, each share of FLIR common stock outstanding immediately prior to the effective time of the merger of Merger Sub I with and into FLIR (the "Effective Time") was converted into the right to receive (i) $28.00 in cash and (ii) 0.0718 shares of Teledyne common stock, with any fractional shares to be paid in cash. The amount shown above represents the gross cash payment, but the actual payment will be less any applicable withholding for taxes. Row 2 · 2021-05-14 · Disposition to issuer · Disposed 68,308 · Balance 0 F2: Pursuant to the Merger Agreement, each FLIR restricted stock unit, including performance-based restricted stock units that were earned but subject to service-based vesting ("FLIR RSU") outstanding immediately prior to the Effective Time automatically vested and was cancelled and converted into the right to receive $56.00 in cash in respect of each share of FLIR common stock subject to such FLIR RSU. |
| Common StockSEC Table I · non-derivative | IndirectChildren's Trust | 0 |
Reported balance
After 2021-05-14 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2021-05-14 · Disposition to issuer · Disposed 30,000 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among Teledyne Technologies Incorporated ("Teledyne"), Firework Merger Sub I, Inc. ("Merger Sub I"), Firework Merger Sub II, LLC, and FLIR Systems, Inc. ("FLIR"), Merger Sub I was merged with and into FLIR on May 14, 2021, with FLIR surviving, and immediately thereafter Merger Sub II was merged with and into FLIR, with Merger Sub II surviving. In connection therewith, each share of FLIR common stock outstanding immediately prior to the effective time of the merger of Merger Sub I with and into FLIR (the "Effective Time") was converted into the right to receive (i) $28.00 in cash and (ii) 0.0718 shares of Teledyne common stock, with any fractional shares to be paid in cash. The amount shown above represents the gross cash payment, but the actual payment will be less any applicable withholding for taxes. |
| Common StockSEC Table I · non-derivative | IndirectSpouse | 0 |
Reported balance
After 2021-05-14 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2021-05-14 · Disposition to issuer · Disposed 176,832 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among Teledyne Technologies Incorporated ("Teledyne"), Firework Merger Sub I, Inc. ("Merger Sub I"), Firework Merger Sub II, LLC, and FLIR Systems, Inc. ("FLIR"), Merger Sub I was merged with and into FLIR on May 14, 2021, with FLIR surviving, and immediately thereafter Merger Sub II was merged with and into FLIR, with Merger Sub II surviving. In connection therewith, each share of FLIR common stock outstanding immediately prior to the effective time of the merger of Merger Sub I with and into FLIR (the "Effective Time") was converted into the right to receive (i) $28.00 in cash and (ii) 0.0718 shares of Teledyne common stock, with any fractional shares to be paid in cash. The amount shown above represents the gross cash payment, but the actual payment will be less any applicable withholding for taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among Teledyne Technologies Incorporated ("Teledyne"), Firework Merger Sub I, Inc. ("Merger Sub I"), Firework Merger Sub II, LLC, and FLIR Systems, Inc. ("FLIR"), Merger Sub I was merged with and into FLIR on May 14, 2021, with FLIR surviving, and immediately thereafter Merger Sub II was merged with and into FLIR, with Merger Sub II surviving. In connection therewith, each share of FLIR common stock outstanding immediately prior to the effective time of the merger of Merger Sub I with and into FLIR (the "Effective Time") was converted into the right to receive (i) $28.00 in cash and (ii) 0.0718 shares of Teledyne common stock, with any fractional shares to be paid in cash. The amount shown above represents the gross cash payment, but the actual payment will be less any applicable withholding for taxes.
F2: Pursuant to the Merger Agreement, each FLIR restricted stock unit, including performance-based restricted stock units that were earned but subject to service-based vesting ("FLIR RSU") outstanding immediately prior to the Effective Time automatically vested and was cancelled and converted into the right to receive $56.00 in cash in respect of each share of FLIR common stock subject to such FLIR RSU.
NxStage Medical, Inc.
Report date February 21, 2019 · Filed February 25, 2019
Section 16 reporting ended · disclosed 2019-02-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 1
1 source rowRow 1 · 2019-02-21 · Disposition to issuer · Disposed 100,232 · Balance 0 F1: Disposed of under Merger Agreement with Fresenius Medical Care Holdings, Inc. in which all outstanding shares of Issuer's Common Stock were converted into the right to receive $30 per share in cash. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.16 · Expires 2024-05-21 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-02-21 · Disposition to issuer · Disposed 23,394 · Balance 0 F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.81 · Expires 2025-05-20 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-02-21 · Disposition to issuer · Disposed 19,724 · Balance 0 F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.32 · Expires 2023-05-25 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-02-21 · Disposition to issuer · Disposed 15,854 · Balance 0 F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.78 · Expires 2024-05-24 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-02-21 · Disposition to issuer · Disposed 15,643 · Balance 0 F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of under Merger Agreement with Fresenius Medical Care Holdings, Inc. in which all outstanding shares of Issuer's Common Stock were converted into the right to receive $30 per share in cash.
F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 26, 2026 Filed Jul 1, 2026 00:32 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $5.17 Strike: $5.17 | $129,250.00 |
DisclosureSEC source: 0001537435-26-000044 · wk-form4_1782865962.xml · derivative · entry 1 Lewis Earl · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2036-06-26 F1 · derivative.exercise_date: Vests 25% per year Read SEC document |
| March 27, 2026 Filed Mar 27, 2026 18:44 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 5,000 | $2.52 | $12,596.00 |
DisclosureSEC source: 0001230427-26-000002 · wk-form4_1774637053.xml · nonDerivative · entry 1 Lewis Earl · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,011,006 F1 · shares: Shares acquired by trust Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 16:10 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 5,000 | $2.88 | $14,408.50 |
DisclosureSEC source: 0001537435-26-000024 · wk-form4_1774627831.xml · nonDerivative · entry 1 Lewis Earl · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,006,006 F1 · shares: Shares acquired by a trust Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 14:57 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $8.35 Strike: $8.35 | $208,750.00 |
DisclosureSEC source: 0001537435-25-000115 · wk-form4_1753714654.xml · derivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,250 Underlying: Common Stock · 25,000 shares Expires 2035-07-24 F1 · derivative.exercise_date: Vests 25% per year Read SEC document |
| May 06, 2025 Filed May 7, 2025 13:26 UTC | TECOGEN INC. TGEN · Entity 6846 | OtherCommon Stock | 6,250 | $1.10 | $6,875.00 |
DisclosureSEC source: 0001537435-25-000031 · wk-form4_1746624379.xml · nonDerivative · entry 3 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,001,006 Read SEC document |
| May 06, 2025 Filed May 7, 2025 13:26 UTC | TECOGEN INC. TGEN · Entity 6846 | OtherCommon Stock | 12,500 | $1.20 | $15,000.00 |
DisclosureSEC source: 0001537435-25-000031 · wk-form4_1746624379.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 994,756 Read SEC document |
| May 06, 2025 Filed May 7, 2025 13:26 UTC | TECOGEN INC. TGEN · Entity 6846 | OtherCommon Stock | 15,000 | $1.75 | $26,250.00 |
DisclosureSEC source: 0001537435-25-000031 · wk-form4_1746624379.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 982,256 Read SEC document |
| May 01, 2025 Filed May 5, 2025 13:37 UTC | TECOGEN INC. TGEN · Entity 6846 | OtherCommon Stock | 240,256 | $2.14 | $514,147.84 |
DisclosureSEC source: 0001537435-25-000027 · wk-form4_1746452229.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 967,256 F1 · kind: Shares issued as payment of principal and accrued interest on Tecogen Inc. promissory note dated September 18, 2024 in favor of Mr. Lewis. Read SEC document |
| November 22, 2024 Filed Dec 6, 2024 14:14 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 100,000 | $0.71 | $71,000.00 |
DisclosureSEC source: 0001537435-24-000126 · wk-form4_1733494467.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 737,000 F1 · shares: Exercise under Stock Option Agreement dated 7/9/2020 Read SEC document |
| November 22, 2024 Filed Mar 25, 2025 21:12 UTC Amendment | TECOGEN INC. TGEN · Entity 6846 | Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.71 Strike: $0.71 | $71,000.00 |
DisclosureSEC source: 0001628280-25-014780 · wk-form4a_1742937119.xml · derivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-07-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2024 Filed Mar 25, 2025 21:12 UTC Amendment | TECOGEN INC. TGEN · Entity 6846 | OtherCommon Stock | 100,000 | $0.71 | $71,000.00 |
DisclosureSEC source: 0001628280-25-014780 · wk-form4a_1742937119.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 727,000 F1 · price: Acquisition by exercise of the right to purchase 100,000 shares for $0.71 per share pursuant to Stock Option Agreement dated 7/9/2020. F2 · balance_after: Following the purchase of 100,000 shares on 11/22/2024, Mr. Lewis owned a total of 727,000 shares, and continued to hold options to purchase 100,000 additional shares at various prices. Read SEC document |
| July 15, 2024 Filed Jul 15, 2024 16:09 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 10,000 | $0.68 | $6,800.00 |
DisclosureSEC source: 0001537435-24-000092 · wk-form4_1721059757.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625,000 Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 20:38 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 10,000 | $0.68 | $6,800.00 |
DisclosureSEC source: 0001537435-24-000094 · wk-form4_1721248690.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · purchase by wife Disclosed balance after: 635,000 Read SEC document |
| July 15, 2024 Filed Mar 25, 2025 21:09 UTC Amendment | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 10,000 | $0.68 | $6,800.00 |
DisclosureSEC source: 0001628280-25-014773 · wk-form4a_1742936974.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625,000 F1 · balance_after: The Form 4 filed on 7/17/2024 regarding the purchase of 10,000 shares on 7/15/2024 was duplicative of the Form 4 filed on 7/15/2024 regarding the purchase of 10,000 shares on 7/15/2024, resulting in the overstatement of the share balance; the balance of shares owned on 7/15/2024 was 625,00 shares rather than 635,000 shares Read SEC document |
| June 06, 2024 Filed Jun 18, 2024 19:48 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantStock Options (Right to Buy) · Derivative | 25,000 | $0.77 Strike: $0.77 | $19,250.00 |
DisclosureSEC source: 0001537435-24-000084 · wk-form4_1718740096.xml · derivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 25,000 shares Expires 2034-06-06 F1 · derivative.exercise_date: Vests 25% per year Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:08 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 5,000 | $0.75 | $3,750.00 |
DisclosureSEC source: 0001537435-24-000055 · wk-form4_1714766908.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 615,000 Read SEC document |
| April 24, 2024 Filed Apr 24, 2024 19:37 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 10,000 | $0.68 | $6,800.00 |
DisclosureSEC source: 0001537435-24-000050 · wk-form4_1713987434.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 610,000 Read SEC document |
| January 24, 2024 Filed Jan 25, 2024 14:29 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 9,152 | $0.78 | $7,138.56 |
DisclosureSEC source: 0001537435-24-000012 · wk-form4_1706192955.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 560,835 Read SEC document |
| January 23, 2024 Filed Jan 23, 2024 22:54 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 10,000 | $0.68 | $6,800.00 |
DisclosureSEC source: 0001537435-24-000010 · wk-form4_1706050436.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 551,683 Read SEC document |
| October 18, 2023 Filed Oct 18, 2023 20:28 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 25,000 | $0.91 | $22,750.00 |
DisclosureSEC source: 0001537435-23-000139 · wk-form4_1697660905.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 541,683 Read SEC document |
| October 09, 2023 Filed Oct 11, 2023 22:58 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 2,000 | $0.80 | $1,600.00 |
DisclosureSEC source: 0001537435-23-000133 · wk-form4_1697065084.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 516,683 Read SEC document |
| October 09, 2023 Filed Apr 16, 2024 21:28 UTC | TECOGEN INC. TGEN · Entity 6846 | OtherCommon Stock | 2,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001537435-24-000040 · wk-form5_1713302901.xml · nonDerivative · entry 11 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600,000 F4 · kind: purchase of 2,000 shares reported did not occur F4 · price: purchase of 2,000 shares reported did not occur Read SEC document |
| October 09, 2023 Filed Dec 6, 2024 14:12 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 2,000 | $0.80 | $1,600.00 |
DisclosureSEC source: 0001537435-24-000124 · wk-form4_1733494335.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 637,000 Read SEC document |
| October 09, 2023 Filed Mar 25, 2025 21:11 UTC Amendment | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 2,000 | $0.80 | $1,600.00 |
DisclosureSEC source: 0001628280-25-014778 · wk-form4a_1742937063.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 627,000 F1 · balance_after: The share balance on the Form 4 filed 12/6/2024 following the reported purchase of 2,000 shares should have been 627,000 shares rather than 637,000 shares because the Form 4 filed 7/17/2024 was duplicative, resulting in a 10,000 share overstatement of the share balance. Read SEC document |
| October 06, 2023 Filed Apr 16, 2024 21:28 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 1,000 | $0.80 | $800.00 |
DisclosureSEC source: 0001537435-24-000040 · wk-form5_1713302901.xml · nonDerivative · entry 10 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 602,000 Read SEC document |
| October 06, 2023 Filed Apr 16, 2024 21:28 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 132 | $0.79 | $104.28 |
DisclosureSEC source: 0001537435-24-000040 · wk-form5_1713302901.xml · nonDerivative · entry 9 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 601,000 Read SEC document |
| October 02, 2023 Filed Apr 16, 2024 21:28 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 5,000 | $0.87 | $4,350.00 |
DisclosureSEC source: 0001537435-24-000040 · wk-form5_1713302901.xml · nonDerivative · entry 8 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600,868 Read SEC document |
| September 26, 2023 Filed Apr 16, 2024 21:28 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 1,000 | $0.90 | $900.00 |
DisclosureSEC source: 0001537435-24-000040 · wk-form5_1713302901.xml · nonDerivative · entry 7 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 595,868 Read SEC document |
| September 14, 2023 Filed Apr 16, 2024 21:28 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 17,216 | $0.93 | $16,010.88 |
DisclosureSEC source: 0001537435-24-000040 · wk-form5_1713302901.xml · nonDerivative · entry 6 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 594,868 Read SEC document |
| September 08, 2023 Filed Sep 11, 2023 12:54 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 10,000 | $0.95 | $9,500.00 |
DisclosureSEC source: 0001537435-23-000112 · wf-form4_169443687535089.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 514,683 Read SEC document |
| September 05, 2023 Filed Sep 6, 2023 14:13 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 10,000 | $1.00 | $10,000.00 |
DisclosureSEC source: 0001537435-23-000108 · wf-form4_169400961175518.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 504,683 Read SEC document |
| August 14, 2023 Filed Aug 17, 2023 15:32 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 1,500 | $1.00 | $1,500.00 |
DisclosureSEC source: 0001537435-23-000098 · wf-form4_169228632953786.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 494,683 Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 19:42 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $1.10 Strike: $1.10 | $27,500.00 |
DisclosureSEC source: 0001537435-23-000073 · wf-form4_168685814839885.xml · derivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 25,000 shares Expires 2033-06-13 F1 · derivative.exercise_date: Vests 25% per year Read SEC document |
| May 15, 2023 Filed May 16, 2023 21:59 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 10,000 | $0.96 | $9,600.00 |
DisclosureSEC source: 0001537435-23-000045 · wf-form4_168427436806895.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 493,183 Read SEC document |
| March 29, 2023 Filed Mar 30, 2023 17:41 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 10,000 | $1.18 | $11,800.00 |
DisclosureSEC source: 0001537435-23-000031 · wf-form4_168019805664497.xml · nonDerivative · entry 8 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 483,183 Read SEC document |
| March 29, 2023 Filed Mar 30, 2023 17:41 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 10,000 | $1.17 | $11,700.00 |
DisclosureSEC source: 0001537435-23-000031 · wf-form4_168019805664497.xml · nonDerivative · entry 7 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 473,183 Read SEC document |
| March 28, 2023 Filed Mar 30, 2023 17:41 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 3,200 | $1.02 | $3,264.00 |
DisclosureSEC source: 0001537435-23-000031 · wf-form4_168019805664497.xml · nonDerivative · entry 6 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 463,183 Read SEC document |
| March 28, 2023 Filed Mar 30, 2023 17:41 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 700 | $1.02 | $710.50 |
DisclosureSEC source: 0001537435-23-000031 · wf-form4_168019805664497.xml · nonDerivative · entry 5 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 459,983 Read SEC document |
| March 28, 2023 Filed Mar 30, 2023 17:41 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 2,100 | $1.03 | $2,163.00 |
DisclosureSEC source: 0001537435-23-000031 · wf-form4_168019805664497.xml · nonDerivative · entry 4 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 459,283 Read SEC document |
| March 27, 2023 Filed Mar 30, 2023 17:41 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 806 | $0.98 | $793.51 |
DisclosureSEC source: 0001537435-23-000031 · wf-form4_168019805664497.xml · nonDerivative · entry 3 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 457,183 Read SEC document |
| March 24, 2023 Filed Mar 30, 2023 17:41 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 2,694 | $0.93 | $2,505.42 |
DisclosureSEC source: 0001537435-23-000031 · wf-form4_168019805664497.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 456,377 Read SEC document |
| March 24, 2023 Filed Mar 30, 2023 17:41 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 5,500 | $0.92 | $5,060.00 |
DisclosureSEC source: 0001537435-23-000031 · wf-form4_168019805664497.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,683 Read SEC document |
| March 22, 2023 Filed Mar 23, 2023 15:50 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 5,000 | $0.87 | $4,350.00 |
DisclosureSEC source: 0001537435-23-000020 · wf-form4_167958659226917.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 448,183 Read SEC document |
| March 20, 2023 Filed Mar 21, 2023 20:10 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 5,000 | $0.87 | $4,350.00 |
DisclosureSEC source: 0001537435-23-000013 · wf-form4_167942943376724.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 443,183 Read SEC document |
| March 20, 2023 Filed Mar 21, 2023 20:10 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 10,000 | $0.90 | $9,000.00 |
DisclosureSEC source: 0001537435-23-000013 · wf-form4_167942943376724.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 438,183 Read SEC document |
| November 29, 2022 Filed Apr 16, 2024 21:28 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001537435-24-000040 · wk-form5_1713302901.xml · nonDerivative · entry 5 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 577,652 F3 · price: ten purchases at $1.43 to $1.57 per share Read SEC document |
| November 23, 2022 Filed Apr 16, 2024 21:28 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 630 | $1.34 | $844.20 |
DisclosureSEC source: 0001537435-24-000040 · wk-form5_1713302901.xml · nonDerivative · entry 4 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 572,652 Read SEC document |
| November 22, 2022 Filed Apr 16, 2024 21:28 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 4,987 | $1.36 | $6,782.32 |
DisclosureSEC source: 0001537435-24-000040 · wk-form5_1713302901.xml · nonDerivative · entry 3 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 572,022 Read SEC document |
| November 22, 2022 Filed Apr 16, 2024 21:28 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 1,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001537435-24-000040 · wk-form5_1713302901.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 567,035 F2 · price: Six purchases at $1.24 to $1.29 per share Read SEC document |
| September 29, 2022 Filed Sep 29, 2022 20:55 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 5,000 | $0.97 | $4,850.00 |
DisclosureSEC source: 0001537435-22-000117 · wf-form4_166448493354176.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,183 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.